275 related articles for article (PubMed ID: 23030700)
1. The correlation of cortactin and fascin-1 expression with clinicopathological parameters in pancreatic and ampulla of Vater adenocarcinoma.
Tsai WC; Lin CK; Lee HS; Gao HW; Nieh S; Chan DC; Jin JS
APMIS; 2013 Mar; 121(3):171-81. PubMed ID: 23030700
[TBL] [Abstract][Full Text] [Related]
2. Palliative pancreaticoduodenectomy in pancreatic and periampullary adenocarcinomas.
Wang SE; Shyr YM; Su CH; Chen TH; Wu CW
Pancreas; 2012 Aug; 41(6):882-7. PubMed ID: 22286381
[TBL] [Abstract][Full Text] [Related]
3. Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater.
Hansel DE; Maitra A; Lin JW; Goggins M; Argani P; Yeo CJ; Piantadosi S; Leach SD; Biankin AV
J Clin Oncol; 2005 Mar; 23(9):1811-8. PubMed ID: 15774774
[TBL] [Abstract][Full Text] [Related]
4. The expression of six biomarkers in the four most common ovarian cancers: correlation with clinicopathological parameters.
Lin CK; Chao TK; Yu CP; Yu MH; Jin JS
APMIS; 2009 Mar; 117(3):162-75. PubMed ID: 19245589
[TBL] [Abstract][Full Text] [Related]
5. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].
Ridwelski K; Meyer F; Schmidt U; Lippert H
Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961
[TBL] [Abstract][Full Text] [Related]
6. Association of cortactin and fascin-1 expression in gastric adenocarcinoma: correlation with clinicopathological parameters.
Tsai WC; Jin JS; Chang WK; Chan DC; Yeh MK; Cherng SC; Lin LF; Sheu LF; Chao YC
J Histochem Cytochem; 2007 Sep; 55(9):955-62. PubMed ID: 17510372
[TBL] [Abstract][Full Text] [Related]
7. Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies?
Westgaard A; Pomianowska E; Clausen OP; Gladhaug IP
Ann Surg Oncol; 2013 Feb; 20(2):430-9. PubMed ID: 22956064
[TBL] [Abstract][Full Text] [Related]
8. Fascin and cortactin expression is correlated with a poor prognosis in hepatocellular carcinoma.
Huang X; Ji J; Xue H; Zhang F; Han X; Cai Y; Zhang J; Ji G
Eur J Gastroenterol Hepatol; 2012 Jun; 24(6):633-9. PubMed ID: 22495401
[TBL] [Abstract][Full Text] [Related]
9. Factors influencing recurrence after curative resection for ampulla of Vater carcinoma.
Park JS; Yoon DS; Kim KS; Choi JS; Lee WJ; Chi HS; Kim BR
J Surg Oncol; 2007 Mar; 95(4):286-90. PubMed ID: 17326125
[TBL] [Abstract][Full Text] [Related]
10. Adenocarcinoma of duodenum and ampulla of Vater: clinicopathology study and expression of p53, c-neu, TGF-alpha, CEA, and EMA.
Zhu L; Kim K; Domenico DR; Appert HE; Howard JM
J Surg Oncol; 1996 Feb; 61(2):100-5. PubMed ID: 8606540
[TBL] [Abstract][Full Text] [Related]
11. Cytokeratins 7, 17, and 20 reactivity in pancreatic and ampulla of vater adenocarcinomas. Percentage of positivity and distribution is affected by the cut-point threshold.
Goldstein NS; Bassi D
Am J Clin Pathol; 2001 May; 115(5):695-702. PubMed ID: 11345833
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of prognosis-associated factors in pancreatic head and peri-ampullary cancer].
Roder JD; Siewert JR
Chirurg; 1992 May; 63(5):410-5. PubMed ID: 1376655
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic features and prognosis of duodenal adenocarcinoma and comparison with ampullary and pancreatic ductal adenocarcinoma.
Zenali M; Overman MJ; Rashid A; Broaddus RB; Wang H; Katz MH; Fleming JB; Abbruzzese JL; Wang H
Hum Pathol; 2013 Dec; 44(12):2792-8. PubMed ID: 24139211
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 and bax influence the prognosis after pancreatoduodenectomy for periampullary adenocarcinoma.
Tomazic A; Pegan V; Ferlan-Marolt K; Pleskovic A; Luzar B
Hepatogastroenterology; 2004; 51(60):1832-7. PubMed ID: 15532837
[TBL] [Abstract][Full Text] [Related]
15. The histopathologic type of the periampullary tumors. Is it important for survival?
Georgescu SO; Neacşu CN; Vintilă D; Popa P; Florea N; Mihailovici MS
Chirurgia (Bucur); 2009; 104(6):697-700. PubMed ID: 20187467
[TBL] [Abstract][Full Text] [Related]
16. Expression of gastric mucin MUC5AC and gastric transcription factor SOX2 in ampulla of vater adenocarcinoma: comparison between expression patterns and histologic subtypes.
Sanada Y; Yoshida K; Konishi K; Oeda M; Ohara M; Tsutani Y
Oncol Rep; 2006 May; 15(5):1157-61. PubMed ID: 16596179
[TBL] [Abstract][Full Text] [Related]
17. Ampulla of vater cancers: T-stage and histological subtype but not Dpc4 expression predict prognosis.
Beghelli S; Orlandini S; Moore PS; Talamini G; Capelli P; Zamboni G; Falconi M; Scarpa A
Virchows Arch; 2002 Jul; 441(1):19-24. PubMed ID: 12111196
[TBL] [Abstract][Full Text] [Related]
18. Tumors of the ampulla of vater: histopathologic classification and predictors of survival.
Carter JT; Grenert JP; Rubenstein L; Stewart L; Way LW
J Am Coll Surg; 2008 Aug; 207(2):210-8. PubMed ID: 18656049
[TBL] [Abstract][Full Text] [Related]
19. Effect of Pancreatic Fistula on Recurrence and Long-Term Prognosis of Periampullary Adenocarcinomas after Pancreaticoduodenectomy.
Serrano PE; Kim D; Kim PT; Greig PD; Moulton CA; Gallinger S; Wei AC; Cleary SP
Am Surg; 2016 Dec; 82(12):1187-1195. PubMed ID: 28234183
[TBL] [Abstract][Full Text] [Related]
20. Cytokeratin-positive cells in the bone marrow from patients with pancreatic, periampullary malignancy and benign pancreatic disease show no prognostic information.
Hugenschmidt H; Labori KJ; Brunborg C; Verbeke CS; Seeberg LT; Bendigtsen Schirmer C; Renolen A; Borgen E; Naume B; Wiedswang G
BMC Cancer; 2020 Nov; 20(1):1107. PubMed ID: 33198661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
